Sei Hyun Ahn
Overview
Explore the profile of Sei Hyun Ahn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2044
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Yoo T, Lee S, Chung I, Kim H, Ko B, et al.
J Breast Cancer
. 2025 Mar;
28(1):11-22.
PMID: 40047087
Purpose: This study analyzed the pathological complete response (pCR) rates, long-term outcomes, and biological features of human epidermal growth factor receptor 2 (HER2)-zero, HER2-low, and HER2-positive breast cancer patients undergoing...
2.
Gwark S, Kim J, Chung I, Kim H, Ko B, Lee J, et al.
Front Oncol
. 2024 Jul;
14:1392592.
PMID: 39007102
Introduction: Male breast cancer (MBC) is a rare condition, and recent research has underscored notable distinctions between MBC and breast cancer in women. This study aimed to assess and contrast...
3.
Shin Y, Kim H, Lee T, Kim S, Lee S, Kim J, et al.
JAMA Netw Open
. 2023 Nov;
6(11):e2344835.
PMID: 38015505
Importance: The number of patients with breast cancer who have children is substantial. However, the emotional burden of this disease and its implication for childhood development remain largely unknown. Objective:...
4.
Lee J, Lee Y, Bae S, Baek S, Kook Y, Cha Y, et al.
JAMA Netw Open
. 2023 Aug;
6(8):e2330961.
PMID: 37647069
Importance: Both high 21-gene recurrence score (RS) and high Ki-67 level are poor prognostic factors in patients with estrogen receptor (ER)-positive ERBB2-negative (ER+/ERBB-) breast cancer; however, a discrepancy between the...
5.
Gwark S, Kim H, Kim J, Chung I, Kim H, Ko B, et al.
Ann Surg Oncol
. 2022 Dec;
30(5):2845-2853.
PMID: 36577865
Background: Breast-conserving surgery (BCS) plus radiotherapy (BCS + RT) has been shown to improve survival compared with mastectomy in patients with early breast cancer; however, whether this superiority is maintained...
6.
Lee J, Kim H, Bae S, Ji J, Lee J, Son B, et al.
JAMA Netw Open
. 2022 Nov;
5(11):e2243935.
PMID: 36441548
Importance: Body mass index (BMI) may affect the 21-gene recurrence score (RS) in patients with ER-positive, ERBB2-negative breast cancer. If high BMI increases genomic risk in ER-positive, ERBB2-negative breast cancer,...
7.
Min K, Han H, Kim E, Lee S, Kim J, Chung I, et al.
Breast J
. 2022 Jun;
2022:9029528.
PMID: 35711889
Introduction: Breast reconstruction has become common after total mastectomy; however, certain types of breast reconstruction may be associated with delayed local recurrence or poor survival. Here, we investigated whether there...
8.
Chae S, Park S, Lee H, Ahn J, Kim S, Jung K, et al.
Sci Rep
. 2022 May;
12(1):7858.
PMID: 35552460
We examined whether F-fluorodeoxyglucose metabolism is associated with distant relapse-free survival (DRFS) and overall survival (OS) in women with estrogen receptor (ER)-positive, HER2-negative breast cancer. This was a cohort study...
9.
Kim H, Lee S, Kim J, Chung I, Kim H, Ko B, et al.
PLoS One
. 2022 Mar;
17(3):e0265533.
PMID: 35294484
Purpose: The aim of this study was to evaluate the chronological changes over 14 years in the survival of Korean patients with breast cancer. We also sought to investigate the...
10.
Gwark S, Ahn H, Yeom J, Yu J, Oh Y, Jeong J, et al.
Cancers (Basel)
. 2021 Dec;
13(24).
PMID: 34944885
The plasma proteome of 51 non-metastatic breast cancer patients receiving neoadjuvant chemotherapy (NCT) was prospectively analyzed by high-resolution mass spectrometry coupled with nano-flow liquid chromatography using blood drawn at the...